The present study sought to elucidate the influence of the genetic status and expression of several genes involved in the NF-κB and EGFR pathways in metastatic NSCLC patients treated with platinum-based chemotherapy (Figure 1). The gene discussed is NFKB1; the disease is non-small cell lung carcinoma.